argenx SE | ARGX - Cost Of Sales

Stock Price
701.00
Daily Change
-5.20 -0.74%
Monthly
2.28%
Yearly
36.22%
Q2 Forecast
678.23

argenx SE reported $121M in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
AstraZeneca USD -204M 3.48B Mar/2026
Genmab DKK 81M 23M Dec/2025
GlaxoSmithKline GBP 1.88B 736M Mar/2026
GRIFOLS EUR 1.08B 214.82M Mar/2026
Hikma Pharmaceutical USD 959M 492.5M Dec/2025
Lakefront Biotherapeutics EUR 4.8M 4.34M Mar/2026
Qiagen NV USD 217.43M 29.65M Dec/2025
UCB EUR 1.07B 146M Dec/2025